Cortria Overview

  • Year Founded
  • 2005

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

Cortria General Information

Description

Developer of medicines for the treatment of cardiovascular diseases. The company's product is used for the treatment of dyslipidemia, an atherogenic disorder characterized by abnormal lipid levels in the bloodstream.

Contact Information

Formerly Known As
Cortria Corp, Pharmena North America Inc
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • Old City Hall
  • 45 School Street
  • Boston, MA 02108
  • United States
+1 (617)
Primary Industry
Pharmaceuticals
Acquirer
Corporate Office
  • Old City Hall
  • 45 School Street
  • Boston, MA 02108
  • United States
+1 (617)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Cortria Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Merger/Acquisition 20-Aug-2010 Completed Clinical Trials - General
2. Early Stage VC (Series B) 10-Jul-2009 Completed Clinical Trials - General
1. Early Stage VC (Series A) 06-Nov-2008 $8.8M $8.8M Completed Product Development
To view Cortria’s complete valuation and funding history, request access »

Cortria Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B
Series A
To view Cortria’s complete cap table history, request access »

Cortria Patents

Cortria Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2009244395-A1 1-methylnicotinamide analogs Inactive 06-May-2008
CA-2722292-A1 1-methylnicotinamide analogs Inactive 06-May-2008
EP-2285379-A1 1-methylnicotinamide analogs Inactive 06-May-2008
EP-2285379-A4 1-methylnicotinamide analogs Inactive 06-May-2008
WO-2009137527-A1 1-methylnicotinamide analogs Inactive 06-May-2008 A61K31/44
To view Cortria’s complete patent history, request access »

Cortria Former Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
CV Ventures Venture Capital Minority
Domain Associates Venture Capital Minority
MVM Partners Growth/Expansion Minority
To view Cortria’s complete investors history, request access »

Cortria FAQs

  • When was Cortria founded?

    Cortria was founded in 2005.

  • Where is Cortria headquartered?

    Cortria is headquartered in Boston, MA.

  • What industry is Cortria in?

    Cortria’s primary industry is Pharmaceuticals.

  • Is Cortria a private or public company?

    Cortria is a Private company.

  • What is Cortria’s current revenue?

    The current revenue for Cortria is .

  • How much funding has Cortria raised over time?

    Cortria has raised $10.6M.

  • Who are Cortria’s investors?

    CV Ventures, Domain Associates, and MVM Partners have invested in Cortria.

  • When was Cortria acquired?

    Cortria was acquired on 20-Aug-2010.

  • Who acquired Cortria?

    Cortria was acquired by Pharmena.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process